|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||26.00|
Mindray Medical International Ltd. has become the latest Chinese company to delist from an American exchange after completing a $1.9 billion privatization deal as a record wave of buyouts continues this ...
Bottom line: The looming completion of buyouts for Qihoo 360 and Mindray Medical points to growing momentum for successful privatizations of other Chinese firms waiting to de-list from New York. Two of the largest in a wave of privatizations by US-listed Chinese firms have just taken big steps forward, with major
NEW YORK, NY / ACCESSWIRE / March 2, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Mindray Medical ...